melanoma

Amtagvi is the first cell therapy for solid tumors approved by the FDA. Iovance Biotherapeutics, Inc. hide caption toggle caption…

Bet_Noire Iovance Biotherapeutics (NASDAQ:IOVA) has received FDA accelerated approval for its T-cell immunotherapy lifileucel, also known as Amtagvi, in the…